Rett Syndrome Completed Phase 2 Trials for Glatiramer (DB05259)

Also known as: Rett's Syndrome / Rett's Disorder / RTT / Rett Disorder / Rett's disorder (disorder)

IndicationStatusPhase
DBCOND0002561 (Rett Syndrome)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02153723Pharmacological Treatment of Rett Syndrome With Glatiramer Acetate (Copaxone)Treatment